These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24298691)

  • 21. Combined use of a TST and the T-SPOT®.TB assay for latent tuberculosis infection diagnosis before anti-TNF-α treatment.
    Jung YJ; Lyu J; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee KH; Lee SD; Kim WS; Kim DS; Shim TS
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1300-6. PubMed ID: 22863375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New tests will improve detection of latent TB.
    Chapman AL
    Practitioner; 2011 Nov; 255(1745):23-6, 2-3. PubMed ID: 22235551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The responses of multiple cytokines following incubation of whole blood from TB patients, latently infected individuals and controls with the TB antigens ESAT-6, CFP-10 and TB7.7.
    Kim SY; Park MS; Kim YS; Kim SK; Chang J; Lee HJ; Cho SN; Kang YA
    Scand J Immunol; 2012 Dec; 76(6):580-6. PubMed ID: 22946827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latent tuberculosis infection treatment for prison inmates: a randomised controlled trial.
    Chan PC; Yang CH; Chang LY; Wang KF; Lu BY; Lu CY; Shao PL; Hsueh PR; Fang CT; Huang LM
    Int J Tuberc Lung Dis; 2012 May; 16(5):633-8. PubMed ID: 22410137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancing the public health impact of latent tuberculosis infection diagnosis and treatment (ACT4): protocol for a cluster randomised trial.
    Oxlade O; Trajman A; Benedetti A; Adjobimey M; Cook VJ; Fisher D; Fox GJ; Fregonese F; Hadisoemarto P; Hill PC; Johnston J; Long R; Obeng J; Ruslami R; Valiquette C; Menzies D
    BMJ Open; 2019 Mar; 9(3):e025831. PubMed ID: 30898826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of failure to complete treatment for latent tuberculosis infection.
    Parsyan AE; Saukkonen J; Barry MA; Sharnprapai S; Horsburgh CR
    J Infect; 2007 Mar; 54(3):262-6. PubMed ID: 16772095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tuberculosis prevalence survey in Japan].
    Shimao T
    Kekkaku; 2009 Nov; 84(11):713-20. PubMed ID: 19999593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative evaluation of T-cell response after specific antigen stimulation in active and latent tuberculosis infection in adults and children.
    Latorre I; De Souza-Galvão M; Ruiz-Manzano J; Lacoma A; Prat C; Fuenzalida L; Altet N; Ausina V; Domínguez J
    Diagn Microbiol Infect Dis; 2009 Nov; 65(3):236-46. PubMed ID: 19822269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [INCREASE IN THE NUMBER OF INFANTS WITH KOCH PHENOMENON AFTER BCG VACCINATION].
    Ito K
    Kekkaku; 2015 Mar; 90(3):421-4. PubMed ID: 26477112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test?
    Soysal A; Toprak D; Koc M; Arikan H; Akoglu E; Bakir M
    Nephrol Dial Transplant; 2012 Apr; 27(4):1645-50. PubMed ID: 21931124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients with psoriasis are more likely to be treated for latent tuberculosis infection prior to biologics than patients with inflammatory bowel disease.
    Bassukas ID; Kosmidou M; Gaitanis G; Tsiouri G; Tsianos E
    Acta Derm Venereol; 2011 Jun; 91(4):444-6. PubMed ID: 21547342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000.
    Bennett DE; Courval JM; Onorato I; Agerton T; Gibson JD; Lambert L; McQuillan GM; Lewis B; Navin TR; Castro KG
    Am J Respir Crit Care Med; 2008 Feb; 177(3):348-55. PubMed ID: 17989346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual skin tests with Mycobacterium avium sensitin and PPD to detect misdiagnosis of latent tuberculosis infection.
    Larson EM; O'Donnell M; Chamblee S; Horsburgh CR; Marsh BJ; Moreland JD; Johnson LS; von Reyn CF
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1504-9, i. PubMed ID: 22008764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-gamma release assay test characteristics depend upon the prevalence of active tuberculosis.
    Davidow AL
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1411-5. PubMed ID: 19861015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The prevalence of latent tuberculosis infections among health-care workers--a three-country comparison].
    Nienhaus A; Schablon A; Tripodi D; Torres Costa J
    Pneumologie; 2011 Dec; 65(12):726-9. PubMed ID: 22006409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Workplace contact investigations in the United States.
    Davidow AL; Mangura BT; Wolman MS; Bur S; Reves R; Thompson V; Ford J; Reichler MR
    Int J Tuberc Lung Dis; 2003 Dec; 7(12 Suppl 3):S446-52. PubMed ID: 14677836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solutions to improve the latent tuberculosis Cascade of Care in Ghana: a longitudinal impact assessment.
    Barss L; Obeng J; Fregonese F; Oxlade O; Adomako B; Afriyie AO; Frimpong ED; Winters N; Valiquette C; Menzies D
    BMC Infect Dis; 2020 May; 20(1):352. PubMed ID: 32423422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barriers to accepting and completing latent tuberculosis infection treatment.
    Kane M; Korn B; Saukkonen J; McDonald C; Walsh C; Waters R; McLaughlin AM; Keane J
    Ir Med J; 2013; 106(7):200-4. PubMed ID: 24218745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for latent tuberculosis in anti-TNF-α candidate patients in a high tuberculosis incidence setting.
    Saidenberg-Kermanac'h N; Semerano L; Naccache JM; Brauner M; Falgarone G; Dumont-Fischer D; Guillot X; Valeyre D; Boissier MC
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1307-14. PubMed ID: 22863801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.